filmov
tv
Tools and methods for CRISPR-Cas9 screening for functional genomics and drug discovery
Показать описание
Presented By:
Louise Baskin, M.S. Molecular Biology and Genetics
Senior Product Manager for Functional Genomics, Thermo Fisher Scientific
Speaker Biography:
Louise has 15 years of experience in product management, marketing, and technical sales of reagents and tools for gene modulation, encompassing primarily RNA interference and CRISPR-Cas9.
She received her Masters Degree in Molecular Biology & Genetics from Northwestern University.
Webinar:
Tools and methods for CRISPR-Cas9 screening for functional genomics and drug discovery
Webinar Abstract:
Loss-of-function studies are an established method for uncovering a gene’s role in a biological pathway or disease state. The advent of CRISPR-Cas9 for gene knockout has given researchers a powerful tool for single-gene studies as well as high-throughput screening applications. Some experimental systems and assays demand solutions that enable long-term phenotypic readout, delivery into difficult-to-transfect cells, and the ability to easily move from pooled to arrayed screening reagents. The Invitrogen™ lentiviral guide RNA portfolio offers a toolset to achieve these goals. We will additionally present a recent case study of how a screen with LentiArray™ gRNA reagents has led to a potential human cancer therapeutic.
Earn PACE Credits:
LabRoots on Social:
SnapChat: labroots_inc
Louise Baskin, M.S. Molecular Biology and Genetics
Senior Product Manager for Functional Genomics, Thermo Fisher Scientific
Speaker Biography:
Louise has 15 years of experience in product management, marketing, and technical sales of reagents and tools for gene modulation, encompassing primarily RNA interference and CRISPR-Cas9.
She received her Masters Degree in Molecular Biology & Genetics from Northwestern University.
Webinar:
Tools and methods for CRISPR-Cas9 screening for functional genomics and drug discovery
Webinar Abstract:
Loss-of-function studies are an established method for uncovering a gene’s role in a biological pathway or disease state. The advent of CRISPR-Cas9 for gene knockout has given researchers a powerful tool for single-gene studies as well as high-throughput screening applications. Some experimental systems and assays demand solutions that enable long-term phenotypic readout, delivery into difficult-to-transfect cells, and the ability to easily move from pooled to arrayed screening reagents. The Invitrogen™ lentiviral guide RNA portfolio offers a toolset to achieve these goals. We will additionally present a recent case study of how a screen with LentiArray™ gRNA reagents has led to a potential human cancer therapeutic.
Earn PACE Credits:
LabRoots on Social:
SnapChat: labroots_inc
0:08:53
2) CRISPR Cas9 - Methods and Tools
0:14:27
CRISPR-Cas9 Genome Editing Technology
0:57:15
Tools and methods for CRISPR-Cas9 screening for functional genomics and drug discovery
0:07:07
3) CRISPR Cas9 - gRNA Design
0:01:39
CRISPR Explained
1:07:25
New RNA tools for optimized CRISPR/Cas9 genome editing
0:04:13
Genome Editing with CRISPR-Cas9
0:10:00
CRISPR Cas9 : How CRISPR can be performed in the lab ?
0:04:32
CRISPR: Gene editing and beyond
0:01:18
How CRISPR Cas9 works (animation explained in 1 minute)
1:02:50
Simplified Online Tools for CRISPR Cas9 Gene Editing Design and Confirmation
0:00:36
CRISPR Simplified: Unleashing the Superpower of Gene Editing
0:35:45
Advanced tools for knock-in genome editing in iPSCs
0:07:49
How to perform a CRISPR Knockout Experiment
0:13:45
LABTalks: CRISPR/Cas9: Simple & versatile genome editing tool
0:18:07
11K - Gene editing using CRISPR/Cas9
0:14:00
CRISPR | CRISPR - CAS9 | Genome Editing Tool
0:59:50
Guide to CRISPR/Cas9 Delivery: How to Maximize Your Editing Efficiency
0:35:04
Lec 26: Computational Resources for CRISPR / Cas - Part A
0:05:29
How CRISPR lets you edit DNA - Andrea M. Henle
0:35:15
Understanding CRISPR-Cas9
0:41:59
Innovative Tools for Efficient CRISPR Cas Genome Engineering
0:06:56
5) CRISPR Cas9 - Screening and Validation Strategies
1:01:20
Novel tools for cell line engineering with CRISPR-Cas9
Комментарии